ABBV
57
-2
MAT
62
2
BEN
33
-5
PEG
46
-9
SBUX
36
-3
CSX
55
-2
FDX
30
-9
ZTS
27
-9
UHS
56
4
THC
62
2
CINF
37
6
DVA
59
4
MPC
28
2
UPS
27
-5
HCP
47
-9
STX
52
2
AAP
30
3
OXY
53
4
ESS
51
4
MRK
25
2
ABBV
57
-2
MAT
62
2
BEN
33
-5
PEG
46
-9
SBUX
36
-3
CSX
55
-2
FDX
30
-9
ZTS
27
-9
UHS
56
4
THC
62
2
CINF
37
6
DVA
59
4
MPC
28
2
UPS
27
-5
HCP
47
-9
STX
52
2
AAP
30
3
OXY
53
4
ESS
51
4
MRK
25
2
Financhill
Back

Altimmune Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
43

ALT
Altimmune

Last Price:
6.79
Seasonality Move:
13.71%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Altimmune Stock Forecast

  • Over the next 52 weeks, Altimmune has on average historically risen by 27.1% based on the past 19 years of stock performance.
  • Altimmune has risen higher in 7 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.84%
  • Is Altimmune Stock Undervalued?
    The current Altimmune [ALT] share price is $6.79. The Score for ALT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • ALT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Altimmune Stock Go Up Next Year?

  • Over the next 52 weeks, Altimmune has on average historically risen by 27.1% based on the past 19 years of stock performance.

Altimmune Stock Rating

Sell
43
Altimmune (ALT) is a Sell

Is Altimmune overpriced?

  • Altimmune has risen higher in 7 of those 19 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.84%

Altimmune Stock Price History

Is ALT stock going to rise?

  • The current trend is moderately bullish and ALT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
altimmune.com

52-Week Data

52-Week High:
14.84
52-Week Low:
2.32

Prediction Charts

Market Cap:
482.57M
Price in USD:
6.79
Volume:
2.06M
Beta:
1.15

Technical Analysis

SMA50:
6.76
SMA100:
6.69
SMA200:
7.72
52-Wk Change:
147.81%

Stock Predictions

  • Is Altimmune stock public?
    Yes, Altimmune is a publicly traded company.
  • What is the Altimmune stock quote today?
    The Altimmune stock price is 6.79 USD today.
  • How to buy Altimmune stock online?
    You can buy Altimmune shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-15 6.46 7.04 7.24 6.43
Oct-16 7.14 6.86 7.14 6.51
Oct-18 6.79 6.88 7.11 6.66
Oct-21 6.90 6.90 6.97 6.63
Oct-22 6.90 6.80 6.96 6.67
Oct-23 6.74 6.72 6.85 6.52
Oct-24 6.74 6.77 6.97 6.65
Oct-25 6.85 6.69 7.05 6.69
Oct-28 6.82 7.01 7.19 6.77
Oct-29 7.04 7.36 7.58 6.85
Oct-30 7.28 6.76 7.31 6.74
Oct-31 6.74 6.75 6.86 6.58
Nov-1 6.82 6.74 7.20 6.62
Nov-4 6.69 6.79 6.84 6.45

Altimmune Earnings

Altimmune Earnings Report: Per Share Altimmune Earnings Q1 Q2 Q3 and Q4 last year and next year.

Altimmune Forecast Revenue Growth

Altimmune Stock Analysis: Historical quarterly revenues per share for Altimmune and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and a decrease next year of $0.29 per share.

* Altimmune stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.